Drugs Online » Prescription Drugs 1 » Accu Chek Softclix
The Accu-Chek Softclix. - So gentle it's virtually painless.And so easy you can use it with just one hand. Virtually Pain Free. The Accu-Chek Softclix uses an extremely precise motion and a fine non-stick silicon coated lancet so you have less tearing of skin or tissue. And that means less pain. With 11 different depth settings on the comfort dial you can choose the most comfortable lancing setting to suit your type of skin.Discrete Style. The Accu-Chek Softclix is a state-of-the-art medical device. The pen-like style makes it discreet and easy to handle. It even has a handy clip for when you're on the move.
Buy Accu Chek Softclix and other Prescription Drugs 1 products online
at Medstore.
Buy Online at Medstore - Click Here!

About Accu Chek Softclix:
Product Type: Prescription Drugs 1
Accu-Chek Softclix
Accu-Chek Softclix
Accu-Chek Softclix
Lancing 25 LNCTS Lancing
Accu-Chek Softclix Accu-Chek Softclix

View more
Prescription Drugs 1
Previous Product Next Product
Drugs Online:
From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.


|